Equity Overview
Price & Market Data
Price: $0.22
Daily Change: +$0.01 / 4.55%
Daily Range: $0.20 - $0.22
Market Cap: $173,187,664
Daily Volume: 78,500
Performance Metrics
1 Week: 18.03%
1 Month: 15.79%
3 Months: 113.8%
6 Months: 214.3%
1 Year: 1,000%
YTD: 7.32%
Details
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company's products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.